Case Study Sameness Evaluation of Octreotide Generic project submission to USFDA

🚨 The Truth About Generic Drug Sameness: What FDA Reviewers Really Look For 🚨 When pharmaceutical companies submit a generic drug application (ANDA), proving "sameness" involves far more than simply matching the active ingredient. For complex peptide drugs like Octreotide, FDA reviewers require extensive analytical evidence demonstrating structural identity, impurity equivalence, degradation behavior, and physicochemical comparability. In this video, we break down what FDA reviewers actually look for during generic drug sameness evaluations and explore a real-world Octreotide ANDA case study. Learn how advanced analytical techniques such as LC-MS/MS, HRMS, peptide mapping, impurity profiling, and forced degradation studies help establish regulatory confidence and support successful ANDA submissions. Whether you're involved in generic drug development, pharmaceutical R&D, peptide characterization, analytical chemistry, regulatory affairs, or ANDA submissions, this video provides valuable insights into the science behind FDA sameness requirements. 📌 What You'll Learn: ✅ What "generic drug sameness" really means ✅ Why peptide generics require advanced characterization ✅ How primary structure and molecular identity are confirmed ✅ The importance of disulfide bond verification ✅ Impurity profiling and related substances evaluation ✅ Physicochemical comparability requirements ✅ Stress testing and degradation studies ✅ FDA expectations for ANDA submissions ✅ Key challenges in peptide generic development ✅ Best practices for regulatory-ready documentation 🔬 Related Blog Article: https://resolvemass.ca/octreotide-sam... Reverse Engineering Risperidone PLGA Microspheres: Controlling Lag Phase Through Polymer Characterization The article explores how polymer characteristics such as molecular weight, lactide:glycolide ratio, end-group chemistry, and crystallinity influence drug release behavior in long-acting injectable PLGA microsphere formulations. It also highlights analytical approaches used for reverse engineering complex generic products. 💡 Who Should Watch? • Pharmaceutical Scientists • Analytical Chemists • Regulatory Affairs Professionals • Generic Drug Developers • ANDA Submission Teams • CRO Scientists • Formulation Development Experts • Peptide Characterization Specialists 📢 If you found this video helpful: 👍 Like the video 💬 Leave your questions in the comments 🔔 Subscribe for more pharmaceutical development and regulatory science content 📨 Contact us for peptide characterization and generic drug analytical support #GenericDrugDevelopment #ANDA #FDA #Octreotide #PeptideCharacterization #LCMSMS #MassSpectrometry #PharmaceuticalAnalysis #AnalyticalChemistry #DrugDevelopment #RegulatoryAffairs #PeptideGenerics #GenericPharmaceuticals #ImpurityProfiling #PharmaceuticalResearch #Bioequivalence #FDAApproval #PharmaIndustry #DrugCharacterization #ResolveMass